innoscripta SE (ETR:1INN)
Germany · Delayed Price · Currency is EUR 79.90
-1.10 (-1.36%)
At close: Sep 11, 2026
innoscripta SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 122.41 | 103.41 | 64.71 | 39.37 | 27.27 | 19.83 | |
Revenue Growth | 42.47% | 59.82% | 64.34% | 44.36% | 37.56% | - |
Cost of Revenue | 34.27 | 30.19 | 19.42 | 18.19 | 13.29 | 8.71 |
Gross Profit | 88.14 | 73.22 | 45.29 | 21.19 | 13.98 | 11.11 |
Other Operating Expenses | 12.3 | 9.55 | 7.78 | 5.48 | 4.68 | 3.13 |
Operating Expenses | 12.59 | 9.74 | 7.96 | 5.63 | 4.84 | 3.26 |
Operating Income | 75.55 | 63.48 | 37.32 | 15.56 | 9.15 | 7.86 |
Interest Expense | -0.2 | -0.05 | -0.09 | -0.08 | -0.06 | -0.21 |
Interest & Investment Income | 0.52 | 0.21 | 0.23 | 0.06 | 0.12 | 0.01 |
Currency Exchange Gain (Loss) | -0.03 | -0.06 | -0.05 | -0.09 | 0.03 | -0 |
Pretax Income | 75.84 | 63.59 | 37.41 | 15.45 | 9.24 | 7.66 |
Income Tax Expense | 24.57 | 20.98 | 12.32 | 5.18 | 3.15 | 2.57 |
Net Income | 51.28 | 42.61 | 25.09 | 10.27 | 6.1 | 5.09 |
Net Income to Common | 51.28 | 42.61 | 25.09 | 10.27 | 6.1 | 5.09 |
Net Income Growth | 51.10% | 69.82% | 144.27% | 68.46% | 19.88% | - |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 0 | - |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 0 | - |
Shares Change | - | - | - | 39900.00% | - | - |
EPS (Basic) | 5.13 | 4.26 | 2.51 | 1.03 | 243.89 | - |
EPS (Diluted) | 5.13 | 4.26 | 2.51 | 1.03 | 243.89 | - |
EPS Growth | 51.10% | 69.82% | 144.27% | -99.58% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 43.74 | 40.64 | 20 | 5.15 | 8.56 | -0.59 |
Free Cash Flow Per Share | 4.37 | 4.06 | 2.00 | 0.52 | 342.41 | - |
Dividend Per Share | 4.000 | 4.000 | 2.400 | 1.600 | 200.000 | - |
Dividend Growth | 66.67% | 66.67% | 50.00% | -99.20% | - | - |
Gross Margin | 72.00% | 70.80% | 69.99% | 53.81% | 51.27% | 56.05% |
Operating Margin | 61.72% | 61.38% | 57.68% | 39.52% | 33.54% | 39.63% |
Profit Margin | 41.89% | 41.20% | 38.78% | 26.09% | 22.36% | 25.65% |
Free Cash Flow Margin | 35.73% | 39.30% | 30.91% | 13.08% | 31.39% | -2.98% |
EBITDA | 75.84 | 63.67 | 37.51 | 15.71 | 9.3 | 7.98 |
EBITDA Margin | 61.96% | 61.57% | 57.97% | 39.91% | 34.10% | 40.25% |
D&A For EBITDA | 0.29 | 0.2 | 0.18 | 0.15 | 0.15 | 0.12 |
EBIT | 75.55 | 63.48 | 37.32 | 15.56 | 9.15 | 7.86 |
EBIT Margin | 61.72% | 61.38% | 57.68% | 39.52% | 33.54% | 39.63% |
Effective Tax Rate | 32.39% | 32.99% | 32.94% | 33.52% | 34.04% | 33.59% |